Recent Finacing
Recent Raise
Sorbent Therapeutics is a Sunnyvale-based biopharma developing non-absorbed polymeric drugs—lead asset CLP-1001—to selectively bind and remove gastrointestinal sodium and water for heart failure, CKD, and hypertension.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors